NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
December 2, 2020
An NCBiotech contract drug development and manufacturing portfolio company, KBI Biopharma, will establish a new $150M, 200-employee manufacturing facility near RTP.
December 1, 2020
North Carolina’s Small Business and Technology Development Center is hosting a two-day workshop for entrepreneurs starting Wednesday, Dec. 2
November 25, 2020
Academic scientists at NC universities receive the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.
November 25, 2020
Former Duke University science educator and researcher and NCBiotech board member James (Jim) Siedow, Ph.D., has died.
November 25, 2020
Verona Pharma has landed an additional $30 million in financing to support its “first-in-class” drug candidate, ensifentrine, targeting chronic obstructive pulmonary disease (COPD).
November 20, 2020
Eli Lilly and Durham gene editing innovator Precision Biosciences announced a research collaboration and exclusive license agreement that could potentially be worth over a half billion dollars
November 18, 2020
Kimberly Smith, M.D., MPH, SVP and head of research and development of ViiV Healthcare in RTP, is hailed as one of the top 20 among 2020’s "Fiercest Women in Life Sciences."
November 17, 2020
IPM Chirana, a global company that makes ventilators to treat critical care patients, has selected Research Triangle Park as the site of its U.S. headquarters.
November 16, 2020
Morrisville-based Locus Biosciences has signed an agreement with a global non-profit to help fund a new CRISPR Cas3 antibacterial therapy to treat recurrent urinary tract infections.
November 16, 2020
Verona Pharma, a British clinical-stage biotech firm with U.S. headquarters in Raleigh, is exploring the option of repurposing its leading drug candidate to treat COVID-19 patients.
November 11, 2020
NCBiotech awarded 11 grants and loans totaling $623,136 to bioscience companies, universities and nonprofit organizations in the first quarter of its fiscal year.
November 9, 2020
Avient Biosciences' new hemp and research and extraction facility is prepared to produce pharmaceutical ingredients.
November 6, 2020
Merck enters an agreement to buy clinical-stage startup VelosBio for $2.75 billion.
November 5, 2020
Raleigh's Advanced Chemotherapy Technologies announces $5.5M in Series A to fund tests of its medical device offering targeted delivery of chemotherapy to the pancreas in humans.
November 3, 2020
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Durham-based BioCryst Pharmaceuticals’ berotralstat a positive scientific opinion through the Early Access to Medicines Scheme.